StonvexLoading…
StonvexStonvexStonvexCore line items from XAIR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2021 2021-03-31 | Annual 2020 2020-03-31 |
|---|---|---|---|---|
Revenue | $3.71M | $1.16M | $873.00K | $1.39M |
Operating Income | $-44.54M | $-63.01M | $-22.21M | $-18.14M |
Net Income | $-46.63M | $-60.24M | $-22.88M | $-19.94M |
EPS (Diluted) | $-0.69 | $-1.82 | $-1.27 | Not available |
Total Assets | $30.06M | $56.96M | $40.52M | $27.43M |
Total Liabilities | $15.72M | $29.77M | $10.06M | $9.34M |
Cash & Equivalents | $4.67M | $11.38M | $34.63M | $19.83M |
Free Cash Flow OCF − CapEx | $-44.10M | $-61.76M | $-20.53M | $-15.29M |
Shares Outstanding | 82.57M | 45.90M | 21.83M | 16.06M |